SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
45.79 |
% |
11.92 |
39.53 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47512 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
42.99 |
% |
2.18 |
5.76 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47517 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
54.46 |
% |
9.53 |
28.58 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47519 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
1 |
post-ischemic value/pre-ischemic value x 100% |
55.17 |
% |
|
|
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
46836 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
67.31 |
% |
3.15 |
9.96 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45914 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
55.67 |
% |
8.36 |
25.09 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45918 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
64.47 |
% |
2.8 |
7.93 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45919 |
461 |
SHR/NCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
54.02 |
% |
8.16 |
25.8 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45921 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
13 |
post-ischemic value/pre-ischemic value x 100% |
50.56 |
% |
3.84 |
13.85 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
48116 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
55.6 |
% |
5.26 |
12.88 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46053 |
461 |
FHH-Chr 8BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
65.49 |
% |
4.58 |
14.48 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46071 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
60.02 |
% |
6.32 |
18.97 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46074 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
56.56 |
% |
3.07 |
12.66 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46078 |
461 |
SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
41.21 |
% |
3.77 |
10.67 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46087 |
461 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
22 |
post-ischemic value/pre-ischemic value x 100% |
63.99 |
% |
3.37 |
15.81 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46090 |
461 |
SS-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
62.14 |
% |
5.72 |
18.96 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46095 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
79.29 |
% |
19.42 |
51.37 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46097 |
461 |
SS-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
68.4 |
% |
3.75 |
11.24 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46106 |
461 |
FHH-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
69.67 |
% |
4.43 |
13.3 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46109 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
53.51 |
% |
7.02 |
22.2 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46115 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
80.44 |
% |
10.93 |
34.56 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46134 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
51.91 |
% |
5.07 |
14.35 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46138 |
461 |
FHH-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
62.81 |
% |
7.14 |
22.59 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46142 |
461 |
FHH-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
42.76 |
% |
2.99 |
7.91 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47073 |
461 |
FHH-Chr 8BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
37.15 |
% |
3.66 |
11.57 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47082 |
461 |
SS-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
25 |
post-ischemic value/pre-ischemic value x 100% |
39.15 |
% |
3.37 |
16.84 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47088 |
461 |
FHH-Chr YBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
51.19 |
% |
3.43 |
10.84 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47090 |
461 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
50.89 |
% |
6.3 |
21.83 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47096 |
461 |
SS-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
30.25 |
% |
1.7 |
4.49 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47097 |
461 |
SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
52.88 |
% |
4.88 |
15.43 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47104 |
461 |
SS-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
42.65 |
% |
4.0 |
16.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47114 |
461 |
SS-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
32.47 |
% |
4.43 |
14.01 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47115 |
461 |
SS-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
54.19 |
% |
3.53 |
9.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47117 |
461 |
SS-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
56.91 |
% |
4.61 |
13.84 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47119 |
461 |
FHH-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
20 |
post-ischemic value/pre-ischemic value x 100% |
57.21 |
% |
4.36 |
19.51 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47127 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
29.06 |
% |
3.05 |
11.8 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47128 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
29.49 |
% |
1.6 |
5.06 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47149 |
461 |
BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
21 |
post-ischemic value/pre-ischemic value x 100% |
57.27 |
% |
3.35 |
15.34 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47155 |
461 |
FHH-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
31.39 |
% |
2.09 |
5.91 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47066 |
461 |
SS-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
54.01 |
% |
4.26 |
12.77 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47091 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
43.5 |
% |
3.5 |
10.51 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47095 |
461 |
FHH-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
39.88 |
% |
2.24 |
7.09 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47136 |
461 |
FHH-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
49.19 |
% |
5.01 |
15.04 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47152 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
62.89 |
% |
5.57 |
18.47 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47156 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
5 |
post-ischemic value/pre-ischemic value x 100% |
43.17 |
% |
6.93 |
15.49 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
47171 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
3 |
post-ischemic value/pre-ischemic value x 100% |
78.01 |
% |
2.23 |
3.87 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45857 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
55.46 |
% |
8.37 |
28.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45913 |
461 |
FHH-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
54.67 |
% |
2.27 |
6.81 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46054 |
461 |
FHH-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
59.69 |
% |
12.7 |
38.11 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46062 |
461 |
SS-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
59.89 |
% |
7.47 |
24.78 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46068 |
461 |
SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
52.46 |
% |
3.95 |
11.17 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46126 |
461 |
SS-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
49.55 |
% |
4.23 |
11.2 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46133 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
70.6 |
% |
3.25 |
14.17 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46137 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
69.38 |
% |
6.02 |
19.02 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46145 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
47.87 |
% |
9.4 |
24.86 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47513 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
36.92 |
% |
7.71 |
24.37 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47516 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
46.62 |
% |
10.16 |
35.21 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45915 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
50.68 |
% |
8.53 |
28.3 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45922 |
461 |
LEW/Crl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
87.57 |
% |
5.32 |
16.83 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45853 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
61.65 |
% |
5.68 |
17.03 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
45712 |
461 |
FHH-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
22 |
post-ischemic value/pre-ischemic value x 100% |
65.22 |
% |
4.3 |
20.15 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46051 |
461 |
SHR/NCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
57.97 |
% |
12.35 |
39.06 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46063 |
461 |
FHH-Chr 8BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
83.3 |
% |
5.73 |
17.18 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46067 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
64.56 |
% |
4.81 |
14.42 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46076 |
461 |
FHH-Chr YBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
66.53 |
% |
5.32 |
16.82 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46079 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
55.37 |
% |
3.7 |
11.71 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46081 |
461 |
SS-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
91.14 |
% |
5.53 |
21.42 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46083 |
461 |
SS-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
65.65 |
% |
4.87 |
20.09 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46100 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
47.17 |
% |
2.87 |
9.06 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46101 |
461 |
SS-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
63.98 |
% |
1.91 |
6.04 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46108 |
461 |
SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
47.3 |
% |
2.58 |
7.3 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46121 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
48 |
post-ischemic value/pre-ischemic value x 100% |
63.61 |
% |
2.61 |
18.06 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46128 |
461 |
BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
62.66 |
% |
5.0 |
21.81 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46144 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
25.13 |
% |
1.46 |
4.14 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47069 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
47.71 |
% |
4.02 |
11.37 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47075 |
461 |
FHH-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
35.61 |
% |
2.71 |
8.12 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47086 |
461 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
37.33 |
% |
7.04 |
24.4 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47101 |
461 |
SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
42.29 |
% |
3.17 |
10.03 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47102 |
461 |
SS-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
59.19 |
% |
3.58 |
10.74 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47106 |
461 |
SS-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
41.11 |
% |
1.74 |
5.23 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47110 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
40.29 |
% |
4.67 |
13.21 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47112 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
48.53 |
% |
8.18 |
20.03 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47116 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
53.38 |
% |
3.75 |
15.47 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47123 |
461 |
SS-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
57.46 |
% |
4.55 |
13.65 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47124 |
461 |
SS-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
62.43 |
% |
4.99 |
15.78 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47126 |
461 |
SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
55.22 |
% |
6.66 |
18.84 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47132 |
461 |
SS-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
22 |
post-ischemic value/pre-ischemic value x 100% |
52.71 |
% |
3.79 |
17.78 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47141 |
461 |
SS-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
59.36 |
% |
3.09 |
13.12 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47151 |
461 |
FHH-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
44.29 |
% |
4.91 |
14.74 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47157 |
461 |
FHH-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
16 |
post-ischemic value/pre-ischemic value x 100% |
43.75 |
% |
6.29 |
25.15 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47062 |
461 |
FHH-Chr 8BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
44.01 |
% |
2.51 |
7.95 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47078 |
461 |
FHH-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
59.55 |
% |
8.38 |
26.5 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47133 |
461 |
SS-Chr YBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
29 |
post-ischemic value/pre-ischemic value x 100% |
47.98 |
% |
3.14 |
16.93 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47142 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
80.02 |
% |
6.54 |
22.66 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
45713 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
3 |
post-ischemic value/pre-ischemic value x 100% |
81.22 |
% |
6.92 |
11.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47887 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
3 |
post-ischemic value/pre-ischemic value x 100% |
73.83 |
% |
5.99 |
10.38 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47891 |
461 |
LEW/Crl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
65.09 |
% |
5.14 |
16.26 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47883 |
461 |
SHR/NCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
78.91 |
% |
4.46 |
13.39 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46060 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
85.8 |
% |
17.96 |
53.87 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46110 |
461 |
FHH-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
76.71 |
% |
8.44 |
22.32 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46129 |
461 |
SS-Chr YBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
26 |
post-ischemic value/pre-ischemic value x 100% |
57.77 |
% |
4.58 |
23.34 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46131 |
461 |
FHH-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
62.0 |
% |
5.11 |
12.52 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46141 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
49.29 |
% |
2.8 |
9.7 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47514 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
76.81 |
% |
2.82 |
6.92 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
46835 |
461 |
FHH-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
75.89 |
% |
7.26 |
19.22 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46125 |
461 |
SS-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
72.36 |
% |
4.16 |
13.16 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46130 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
92 |
post-ischemic value/pre-ischemic value x 100% |
62.8 |
% |
2.23 |
21.36 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46132 |
461 |
SS-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
79.21 |
% |
7.29 |
21.86 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46140 |
461 |
FHH-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
54.75 |
% |
3.24 |
9.18 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46146 |
461 |
FHH-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
49.05 |
% |
4.74 |
14.98 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47065 |
461 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
48.49 |
% |
4.72 |
17.67 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47067 |
461 |
SHR/NCrl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
58.26 |
% |
4.16 |
13.17 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47071 |
461 |
FHH-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
45.1 |
% |
2.68 |
7.57 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47077 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
47.68 |
% |
2.98 |
9.41 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47092 |
461 |
SS-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
57.19 |
% |
4.21 |
15.74 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47094 |
461 |
SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
45.22 |
% |
3.81 |
12.06 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47098 |
461 |
SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
52.52 |
% |
3.24 |
10.24 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47100 |
461 |
FHH-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
54.71 |
% |
2.96 |
9.37 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46055 |
461 |
FHH-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
20 |
post-ischemic value/pre-ischemic value x 100% |
66.78 |
% |
5.28 |
23.63 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46057 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
75.74 |
% |
11.64 |
32.92 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46059 |
461 |
FHH-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
65.4 |
% |
5.57 |
16.7 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46072 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
48.23 |
% |
5.55 |
17.55 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46073 |
461 |
SS-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
70.71 |
% |
6.04 |
25.61 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46077 |
461 |
SS-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
80.0 |
% |
2.9 |
11.23 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46080 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
62.45 |
% |
4.48 |
13.45 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46082 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
51.77 |
% |
5.56 |
14.72 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46084 |
461 |
SS-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
58.82 |
% |
5.72 |
17.15 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46086 |
461 |
SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
57.46 |
% |
9.24 |
29.22 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46093 |
461 |
Crl:CD(SD) |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
63.54 |
% |
2.82 |
8.92 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47884 |
461 |
Crl:CD(SD) |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
67.84 |
% |
7.4 |
23.42 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47886 |
461 |
LE/BluGill |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
57.9 |
% |
5.02 |
15.07 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47888 |
461 |
F344/DuCrl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
56.39 |
% |
7.12 |
22.52 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47892 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
45.08 |
% |
2.81 |
7.96 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47105 |
461 |
SS-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
59.4 |
% |
3.47 |
15.14 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47113 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
53.84 |
% |
4.3 |
10.53 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47118 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
47 |
post-ischemic value/pre-ischemic value x 100% |
44.87 |
% |
2.27 |
15.58 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47139 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
61.26 |
% |
6.5 |
19.5 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47145 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
66.0 |
% |
4.33 |
8.66 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47070 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
55.33 |
% |
5.02 |
13.28 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47076 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
52.01 |
% |
4.08 |
12.25 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47087 |
461 |
SS-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
38.44 |
% |
4.65 |
11.4 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47144 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
5 |
post-ischemic value/pre-ischemic value x 100% |
38.74 |
% |
3.13 |
6.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47150 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
2 |
post-ischemic value/pre-ischemic value x 100% |
64.92 |
% |
5.27 |
7.45 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45861 |
461 |
LE/BluGill |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
65.87 |
% |
8.9 |
25.16 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47893 |
461 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
54.99 |
% |
5.6 |
21.67 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46056 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
63.91 |
% |
3.95 |
11.84 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46064 |
461 |
SS-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
65.65 |
% |
3.49 |
11.02 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46070 |
461 |
SS-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
24 |
post-ischemic value/pre-ischemic value x 100% |
63.29 |
% |
4.57 |
22.4 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46116 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
56.6 |
% |
5.4 |
13.24 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47515 |
461 |
SHR/NCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
34.42 |
% |
12.12 |
38.33 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45916 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
71.34 |
% |
12.73 |
38.19 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45917 |
461 |
Crl:CD(SD) |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
52.16 |
% |
2.18 |
6.55 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45854 |
461 |
Crl:CD(SD) |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
59.6 |
% |
6.76 |
20.29 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45856 |
461 |
WKY/NCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
70.91 |
% |
6.22 |
19.67 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45860 |
461 |
F344/DuCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
71.83 |
% |
10.26 |
30.79 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45862 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
243.29 |
% |
80.08 |
196.16 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
46833 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
49.61 |
% |
2.83 |
8.95 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47103 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
43.09 |
% |
4.94 |
15.64 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47107 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
49.03 |
% |
9.9 |
19.8 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47108 |
461 |
SS-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
65.55 |
% |
4.53 |
16.95 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47109 |
461 |
SS-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
47.46 |
% |
4.19 |
17.77 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47111 |
461 |
FHH-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
20 |
post-ischemic value/pre-ischemic value x 100% |
57.7 |
% |
3.95 |
17.67 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47120 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
16 |
post-ischemic value/pre-ischemic value x 100% |
52.79 |
% |
4.3 |
17.2 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47125 |
461 |
FHH-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
45.03 |
% |
1.57 |
4.96 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47129 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
53.58 |
% |
6.45 |
27.37 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47134 |
461 |
FHH-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
51.0 |
% |
4.82 |
13.63 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47135 |
461 |
SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
48.99 |
% |
3.5 |
11.07 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47137 |
461 |
SS-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
66.81 |
% |
6.88 |
28.37 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47147 |
461 |
FHH-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
41.32 |
% |
2.69 |
8.51 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47153 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
11.82 |
% |
11.82 |
23.65 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
47170 |
461 |
WKY/NCrl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
53.59 |
% |
3.91 |
11.74 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47882 |
461 |
SS-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
66.03 |
% |
5.19 |
15.56 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46069 |
461 |
FHH-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
64.74 |
% |
4.52 |
14.29 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46075 |
461 |
SS-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
58.82 |
% |
5.59 |
16.77 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46088 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
53.91 |
% |
5.6 |
15.83 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46094 |
461 |
SS-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
90.04 |
% |
16.21 |
51.25 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46098 |
461 |
SS-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
74.79 |
% |
1.99 |
5.97 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46102 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
57.81 |
% |
17.38 |
45.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46105 |
461 |
FHH-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
62.69 |
% |
4.12 |
13.02 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46119 |
461 |
SS-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
65.72 |
% |
6.09 |
17.22 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46127 |
461 |
SS-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
23 |
post-ischemic value/pre-ischemic value x 100% |
42.33 |
% |
5.42 |
25.99 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47079 |
461 |
SS-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
41.53 |
% |
2.44 |
7.73 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47080 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
54.4 |
% |
2.4 |
10.47 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47084 |
461 |
SS-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
45.36 |
% |
4.91 |
13.9 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47099 |
461 |
FHH-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
12 |
post-ischemic value/pre-ischemic value x 100% |
30.85 |
% |
5.02 |
17.38 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47068 |
461 |
SHR/NCrl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
47.62 |
% |
9.16 |
34.26 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47074 |
461 |
SS-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
49.61 |
% |
2.41 |
6.38 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47081 |
461 |
SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
52.69 |
% |
6.13 |
26.74 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47089 |
461 |
FHH-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
40.76 |
% |
4.43 |
12.52 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47093 |
461 |
SS-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
20 |
post-ischemic value/pre-ischemic value x 100% |
67.56 |
% |
4.46 |
19.96 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47138 |
461 |
SS-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
39.47 |
% |
2.32 |
6.15 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47146 |
461 |
SS-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
39.86 |
% |
9.5 |
26.86 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
47169 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
62.74 |
% |
13.68 |
33.5 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
46834 |
461 |
WKY/NCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
72.19 |
% |
4.69 |
14.82 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45852 |
461 |
LE/BluGill |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
58.14 |
% |
2.51 |
7.54 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45863 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
56.75 |
% |
5.32 |
14.08 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46058 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
72.41 |
% |
4.51 |
13.52 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46112 |
461 |
FHH-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
73.52 |
% |
6.79 |
17.95 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46114 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
78.72 |
% |
11.48 |
32.48 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
47518 |
461 |
LE/BluGill |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
60.86 |
% |
5.74 |
19.04 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45858 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
60.33 |
% |
12.89 |
38.67 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Dyets |
45920 |
461 |
WKY/NCrl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
63.79 |
% |
5.5 |
17.4 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47890 |
461 |
FHH-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
57.45 |
% |
5.19 |
14.69 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46096 |
461 |
SS-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
57.8 |
% |
7.98 |
23.95 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46099 |
461 |
SS-Chr 9BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
65.89 |
% |
6.36 |
24.65 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46103 |
461 |
SS-Chr 6BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
50.19 |
% |
8.76 |
27.71 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46104 |
461 |
SS-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
24 |
post-ischemic value/pre-ischemic value x 100% |
70.73 |
% |
5.4 |
26.46 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46111 |
461 |
SS-Chr 17BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
73.71 |
% |
5.03 |
15.9 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46113 |
461 |
FHH-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
66.87 |
% |
2.91 |
8.22 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46117 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
13 |
post-ischemic value/pre-ischemic value x 100% |
82.0 |
% |
4.15 |
14.96 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46123 |
461 |
SS-Chr 4BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
80.74 |
% |
2.83 |
8.48 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46136 |
461 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
41.68 |
% |
4.12 |
15.43 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47063 |
461 |
GH/OmrMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
53.44 |
% |
5.49 |
14.52 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47121 |
461 |
SS-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
48.31 |
% |
1.42 |
4.7 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47122 |
461 |
FHH-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
5 |
post-ischemic value/pre-ischemic value x 100% |
46.79 |
% |
6.82 |
15.24 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47130 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
97 |
post-ischemic value/pre-ischemic value x 100% |
46.49 |
% |
1.74 |
17.11 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47143 |
461 |
SS-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
56.79 |
% |
10.41 |
29.44 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
47172 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
68.83 |
% |
4.65 |
13.94 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46061 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
70.44 |
% |
6.3 |
15.43 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46065 |
461 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
58.5 |
% |
3.72 |
15.78 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46085 |
461 |
SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
50.28 |
% |
4.11 |
15.91 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46089 |
461 |
SS-Chr 12BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
51.91 |
% |
3.03 |
9.1 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46091 |
461 |
FHH-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
54.91 |
% |
3.73 |
11.2 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46092 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
33.83 |
% |
4.05 |
12.15 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47064 |
461 |
SS-Chr 5BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
39.65 |
% |
4.17 |
12.52 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47072 |
461 |
FHH-Chr 20BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
44.31 |
% |
4.08 |
12.24 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47083 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
51.44 |
% |
4.07 |
12.21 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47085 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
20 |
post-ischemic value/pre-ischemic value x 100% |
61.26 |
% |
4.99 |
22.3 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47131 |
461 |
FHH-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
49.25 |
% |
8.18 |
21.63 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47140 |
461 |
SS/JrHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
16 |
post-ischemic value/pre-ischemic value x 100% |
56.18 |
% |
3.93 |
15.71 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47148 |
461 |
BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
23 |
post-ischemic value/pre-ischemic value x 100% |
55.18 |
% |
3.21 |
15.39 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47154 |
461 |
FHH-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
39.21 |
% |
5.97 |
18.87 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47158 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
5 |
post-ischemic value/pre-ischemic value x 100% |
47.86 |
% |
4.55 |
10.18 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
47173 |
461 |
Hsd:SD |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
49.04 |
% |
6.43 |
21.32 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
48117 |
461 |
F344/DuCrl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
58.95 |
% |
4.3 |
13.59 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45855 |
461 |
LEW/Crl |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
86.75 |
% |
3.18 |
10.05 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
45859 |
461 |
F344/DuCrl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
55.89 |
% |
2.3 |
7.26 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47885 |
461 |
LEW/Crl |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
56.32 |
% |
4.71 |
13.31 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47889 |
461 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
59.38 |
% |
3.7 |
13.86 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46052 |
461 |
FHH-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
68.56 |
% |
10.42 |
27.56 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46066 |
461 |
FHH-Chr 14BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
66.76 |
% |
7.93 |
19.42 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46107 |
461 |
FHH/EurMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
61.61 |
% |
2.87 |
12.5 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46118 |
461 |
SS-Chr 16BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
13 |
post-ischemic value/pre-ischemic value x 100% |
81.05 |
% |
5.94 |
21.41 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46120 |
461 |
FHH-Chr 19BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
71.6 |
% |
6.55 |
20.72 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46122 |
461 |
FHH-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
90.07 |
% |
7.52 |
22.57 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46124 |
461 |
SS-Chr 1BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
55.6 |
% |
6.74 |
19.05 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46135 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
55.35 |
% |
4.42 |
13.98 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46139 |
461 |
BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
54.05 |
% |
4.54 |
19.26 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46143 |
461 |
FHH-Chr 7BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
71.83 |
% |
4.82 |
15.24 |
Download Values
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46147 |
461 |